FDA issued a Warning Letter to Sunrise Pharmaceutical, Inc. on 1/14/2010 for a later inspection.
483 Sunrise Pharmaceutical Feb 2007

483 Sunrise Pharmaceutical Feb 2007

Amy Cramer FDA$119.00 - Available Now

FDA investigators audited the Sunrise Pharmaceutical - Rahway, NJ, United States facility and issued inspectional observations (via FDA 483) on 22 Feb 2007.

Product details

  • Category: Human Drugs
  • Inspection end: 22 Feb 2007
  • Location: Rahway, United States
  • FEI: 3004813394
Add To Cart